Activity of OSE-2101 in HLA-A2+non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorBesse, B.
dc.contributor.authorGarcia Campelo, M. R.
dc.contributor.authorCobo Dols, M. A.
dc.contributor.authorQuoix, E.
dc.contributor.authorMadroszyk, A.
dc.contributor.authorFelip, E.
dc.contributor.authorCappuzzo, F.
dc.contributor.authorDenis, F.
dc.contributor.authorHilgers, W.
dc.contributor.authorRomano, G.
dc.contributor.authorDebieuvre, D.
dc.contributor.authorBaldini, E.
dc.contributor.authorGaletta, D.
dc.contributor.authorViteri, S.
dc.contributor.authorPhan, M.
dc.contributor.authorSchuette, W.
dc.contributor.authorZer, A.
dc.contributor.authorCostantini, D.
dc.contributor.authorDziadziuszko, R.
dc.contributor.authorGiaccone, G.
dc.contributor.authoraffiliation[Besse, B.] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
dc.contributor.authoraffiliation[Garcia Campelo, M. R.] Inst Investigac Biomed A Coruna INIBIC, Dept Med Oncol, La Coruna, Spain
dc.contributor.authoraffiliation[Cobo Dols, M. A.] UGC Oncol Hosp Univ Reg & Virgen Victoria IBIMA, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Quoix, E.] Hop Univ Strasbourg, Pneumol Dept, Nouvel Hop Civil, Strasbourg, France
dc.contributor.authoraffiliation[Madroszyk, A.] Inst Paoli Calmettes, Med Oncol, Marseille, France
dc.contributor.authoraffiliation[Felip, E.] Vall dHebron Univ Hosp, Med Oncol Serv, Thorac Canc Unit, Barcelona, Spain
dc.contributor.authoraffiliation[Cappuzzo, F.] Ist Nazl Tumori IRCCS Regina Elena, Med Oncol, Rome, Italy
dc.contributor.authoraffiliation[Denis, F.] Inst Interreg Cancerol Jean Bernard Elsan, Oncol Radiotherapie, Le Mans, France
dc.contributor.authoraffiliation[Hilgers, W.] Inst Ste Catherine, Med Oncol, Avignon, France
dc.contributor.authoraffiliation[Romano, G.] Osped Vito Fazzi, Oncol, Lecce, Italy
dc.contributor.authoraffiliation[Debieuvre, D.] Hop Emile Muller, Serv Pneumol, Mulhouse, France
dc.contributor.authoraffiliation[Baldini, E.] Osped San Luca, Oncol, Lucca, Italy
dc.contributor.authoraffiliation[Galetta, D.] Ist Tumori Bari Giovanni Paolo II IRCCS, Med Oncol Dept, Bari, Italy
dc.contributor.authoraffiliation[Viteri, S.] Hosp Univ Dexeus, Inst Oncol Dr Rosell, Dept Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Phan, M.] UOMI Canc Ctr, Clin Mi Tres Torres, Barcelona, Spain
dc.contributor.authoraffiliation[Schuette, W.] Stephenson Canc Ctr, Oncol, Oklahoma City, OK USA
dc.contributor.authoraffiliation[Zer, A.] Rabin Med Ctr, Med Oncol, Davidoff Canc Ctr, Beilinson Campus, Petah Tiqwa, Israel
dc.contributor.authoraffiliation[Costantini, D.] OSE Immunotherapeut, Dev, Paris, France
dc.contributor.authoraffiliation[Dziadziuszko, R.] Med Univ Gdansk, Oncol & Radiotherapy, Gdansk, Poland
dc.contributor.authoraffiliation[Giaccone, G.] Weill Cornell Med, Med Oncol, New York, NY USA
dc.contributor.funderOSE Immunotherapeutics
dc.date.accessioned2025-01-07T15:15:47Z
dc.date.available2025-01-07T15:15:47Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.2126
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.2126
dc.identifier.urihttps://hdl.handle.net/10668/26997
dc.identifier.wosID700527704005
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.numberS1325-S1325
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleActivity of OSE-2101 in HLA-A2+non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen de la Victoria
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía